CollPlant Biotechnologies (CLGN) Other Operating Expenses (2018 - 2022)
CollPlant Biotechnologies' (CLGN) quarterly Other Operating Expenses came in at -$3.7 million in Q1 2022, down 100.06% on a QoQ basis from $5.8 billion in Q4 2020.
CollPlant Biotechnologies (CLGN) Other Operating Expenses (2018 - 2022) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Other Operating Expenses data on file, last reported at -$3.7 million in Q1 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$3.7 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$3.7 million (changed N/A YoY) and the FY2020 annual result came in at -$228000.0, up 95.23% from the prior year.
- Other Operating Expenses retreated to -$3.7 million in Q1 2022, from $5.8 billion in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $5.8 billion in Q4 2020 to a low of -$2.0 billion in Q3 2020.
- A 4-year average of $424.1 million and a median of -$227000.0 in 2018 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2019 — Other Operating Expenses slumped 1464.48% — and 2020, when it surged 127853.98%.
- Tracing CLGN's Other Operating Expenses over 4 years: stood at -$290000.0 in 2018, then tumbled by 1464.48% to -$4.5 million in 2019, then surged by 127853.98% to $5.8 billion in 2020, then plunged by 100.06% to -$3.7 million in 2022.
- The last three Other Operating Expenses figures came in at -$3.7 million (Q1 2022), $5.8 billion (Q4 2020), and -$2.0 billion (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2020 | 5.80 Bn |
| Sep 30, 2020 | -1.97 Bn |
| Dec 31, 2019 | -4.54 Mn |
| Jun 30, 2019 | -163,000.00 |
| Mar 31, 2019 | 432,000.00 |
| Dec 31, 2018 | -290,000.00 |
| Sep 30, 2018 | -227,000.00 |
| Mar 31, 2018 | 99,000.00 |